Literature DB >> 22244763

Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism.

Travis S Hughes1, Michael J Chalmers, Scott Novick, Dana S Kuruvilla, Mi Ra Chang, Theodore M Kamenecka, Mark Rance, Bruce A Johnson, Thomas P Burris, Patrick R Griffin, Douglas J Kojetin.   

Abstract

Ligand binding to proteins is not a static process, but rather involves a number of complex dynamic transitions. A flexible ligand can change conformation upon binding its target. The conformation and dynamics of a protein can change to facilitate ligand binding. The conformation of the ligand, however, is generally presumed to have one primary binding mode, shifting the protein conformational ensemble from one state to another. We report solution nuclear magnetic resonance (NMR) studies that reveal peroxisome proliferator-activated receptor γ (PPARγ) modulators can sample multiple binding modes manifesting in multiple receptor conformations in slow conformational exchange. Our NMR, hydrogen/deuterium exchange and docking studies reveal that ligand-induced receptor stabilization and binding mode occupancy correlate with the graded agonist response of the ligand. Our results suggest that ligand and receptor dynamics affect the graded transcriptional output of PPARγ modulators.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22244763      PMCID: PMC3278220          DOI: 10.1016/j.str.2011.10.018

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  41 in total

Review 1.  Implications of protein flexibility for drug discovery.

Authors:  Simon J Teague
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

2.  Using NMRView to visualize and analyze the NMR spectra of macromolecules.

Authors:  Bruce A Johnson
Journal:  Methods Mol Biol       Date:  2004

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity.

Authors:  Laura Guasch; Esther Sala; Cristina Valls; Mayte Blay; Miquel Mulero; Lluís Arola; Gerard Pujadas; Santiago Garcia-Vallvé
Journal:  J Comput Aided Mol Des       Date:  2011-06-21       Impact factor: 3.686

5.  Benzoyl 2-methyl indoles as selective PPARgamma modulators.

Authors:  John J Acton; Regina M Black; A Brian Jones; David E Moller; Lawrence Colwell; Thomas W Doebber; Karen L Macnaul; Joel Berger; Harold B Wood
Journal:  Bioorg Med Chem Lett       Date:  2005-01-17       Impact factor: 2.823

6.  Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A.

Authors:  Daryl A Bosco; Elan Z Eisenmesser; Susan Pochapsky; Wesley I Sundquist; Dorothee Kern
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

7.  Methods for the Analysis of High Precision Differential Hydrogen Deuterium Exchange Data.

Authors:  Michael J Chalmers; Bruce D Pascal; Scooter Willis; Jun Zhang; Stephen J Iturria; Jeffery A Dodge; Patrick R Griffin
Journal:  Int J Mass Spectrom       Date:  2011-04-30       Impact factor: 1.986

8.  Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.

Authors:  Joel P Berger; Ann E Petro; Karen L Macnaul; Linda J Kelly; Bei B Zhang; Karen Richards; Alex Elbrecht; Bruce A Johnson; Gaochao Zhou; Thomas W Doebber; Chhabi Biswas; Mona Parikh; Neelam Sharma; Michael R Tanen; G Marie Thompson; John Ventre; Alan D Adams; Ralph Mosley; Richard S Surwit; David E Moller
Journal:  Mol Endocrinol       Date:  2003-01-16

9.  Partial agonists activate PPARgamma using a helix 12 independent mechanism.

Authors:  John B Bruning; Michael J Chalmers; Swati Prasad; Scott A Busby; Theodore M Kamenecka; Yuanjun He; Kendall W Nettles; Patrick R Griffin
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

10.  Accurate structural correlations from maximum likelihood superpositions.

Authors:  Douglas L Theobald; Deborah S Wuttke
Journal:  PLoS Comput Biol       Date:  2008-02       Impact factor: 4.475

View more
  61 in total

1.  The natural compound, formononetin, extracted from Astragalus membranaceus increases adipocyte thermogenesis by modulating PPARγ activity.

Authors:  Tao Nie; Shiting Zhao; Liufeng Mao; Yiting Yang; Wei Sun; Xiaoliang Lin; Shuo Liu; Kuai Li; Yirong Sun; Peng Li; Zhiguang Zhou; Shaoqiang Lin; Xiaoyan Hui; Aimin Xu; Chung Wah Ma; Yong Xu; Cunchuan Wang; P Rod Dunbar; Donghai Wu
Journal:  Br J Pharmacol       Date:  2018-03-14       Impact factor: 8.739

2.  Quantitative structural assessment of graded receptor agonism.

Authors:  Jinsai Shang; Richard Brust; Patrick R Griffin; Theodore M Kamenecka; Douglas J Kojetin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

3.  Modification of the Orthosteric PPARγ Covalent Antagonist Scaffold Yields an Improved Dual-Site Allosteric Inhibitor.

Authors:  Richard Brust; Hua Lin; Jakob Fuhrmann; Alice Asteian; Theodore M Kamenecka; Douglas J Kojetin
Journal:  ACS Chem Biol       Date:  2017-02-16       Impact factor: 5.100

Review 4.  Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Mol Pharmacol       Date:  2012-08-06       Impact factor: 4.436

5.  Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone.

Authors:  Sarah A Mosure; Jinsai Shang; Jerome Eberhardt; Richard Brust; Jie Zheng; Patrick R Griffin; Stefano Forli; Douglas J Kojetin
Journal:  J Med Chem       Date:  2019-02-07       Impact factor: 7.446

6.  Couple dynamics: PPARγ and its ligand partners.

Authors:  Shanghai Yu; H Eric Xu
Journal:  Structure       Date:  2012-01-11       Impact factor: 5.006

7.  Solution Nuclear Magnetic Resonance Studies of the Ligand-Binding Domain of an Orphan Nuclear Receptor Reveal a Dynamic Helix in the Ligand-Binding Pocket.

Authors:  Nicolas Daffern; Zhonglei Chen; Yongbo Zhang; Leslie Pick; Ishwar Radhakrishnan
Journal:  Biochemistry       Date:  2018-03-22       Impact factor: 3.162

8.  Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism.

Authors:  Jie Zheng; Cesar Corzo; Mi Ra Chang; Jinsai Shang; Vinh Q Lam; Richard Brust; Anne-Laure Blayo; John B Bruning; Theodore M Kamenecka; Douglas J Kojetin; Patrick R Griffin
Journal:  Structure       Date:  2018-08-23       Impact factor: 5.006

9.  Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.

Authors:  Xavier Nadal; Carmen Del Río; Salvatore Casano; Belén Palomares; Carlos Ferreiro-Vera; Carmen Navarrete; Carolina Sánchez-Carnerero; Irene Cantarero; Maria Luz Bellido; Stefan Meyer; Gaetano Morello; Giovanni Appendino; Eduardo Muñoz
Journal:  Br J Pharmacol       Date:  2017-11-02       Impact factor: 8.739

10.  Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment.

Authors:  Xu Liu; Yashuo Wang; Jennifer S Gutierrez; Jesse M Damsker; Kanneboyina Nagaraju; Eric P Hoffman; Eric A Ortlund
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.